American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 213,252 | 191,762 | 207,806 | 205,719 | 205,952 |
| Cost of Goods | 153,016 | 148,181 | 148,525 | 145,939 | 141,468 |
| Gross Profit | 60,236 | 43,581 | 59,281 | 59,780 | 64,484 |
| Operating Expenses | 42,623 | 41,137 | 36,857 | 36,609 | 69,262 |
| Operating Income | 17,629 | 2,625 | 22,949 | 24,110 | -4,310 |
| Interest Expense | 11,541 | 8,750 | 8,797 | 8,242 | 8,136 |
| Other Income | -304 | 1,682 | 5,438 | -3,480 | 1,736 |
| Pre-tax Income | 5,784 | -4,443 | 19,590 | 12,388 | -10,710 |
| Income Tax | 644 | 702 | 8,416 | -124 | -2,327 |
| Net Income Continuous | 5,140 | -5,145 | 11,174 | 12,512 | -8,383 |
| Minority Interests | 13,318 | 5,334 | 11,746 | 13,246 | 15,276 |
| Net Income | $-8,178 | $-10,479 | $-572 | $-734 | $-23,659 |
| EPS Basic Total Ops | -0.22 | -0.35 | -0.06 | -0.04 | -0.78 |
| EPS Basic Continuous Ops | 0.16 | -0.16 | 0.35 | 0.39 | -0.26 |
| EPS Diluted Total Ops | -0.22 | -0.35 | -0.06 | -0.04 | -0.78 |
| EPS Diluted Continuous Ops | 0.16 | -0.16 | 0.35 | 0.39 | -0.26 |
| EBITDA(a) | $28,647 | $13,177 | $33,888 | $34,528 | $5,996 |